Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
An open-label, randomized, 3-arm study in 162 healthy adult subjects with the following primary objective: To assess the systemic absorption and pharmacokinetics of BEMT from 3 market image sunscreen formulations under maximal-use conditions.
Epistemonikos ID: 8eef9612963c7b6197b693f1a2e7a0fd183ed357
First added on: May 10, 2024